Lonye Technology

Lonye Technology is a clinical-stage biotechnology company based in Shanghai, China, specializing in the development of mRNA-based therapeutics and vaccines. The company has built an integrated platform encompassing mRNA sequence design, chemical synthesis of modified nucleotides, and proprietary lipid nanoparticle (LNP) delivery technology. Lonye's primary focus is on addressing infectious diseases and oncology through its innovative nucleic acid drug pipeline. Its lead candidate, an mRNA vaccine for COVID-19, has entered clinical trials, demonstrating the platform's capability for rapid development and scale-up. The company aims to become a leader in the mRNA field by combining cutting-edge research with robust GMP manufacturing capabilities.